Get started
Author

Chetan Ashok

Observed names: Ashok Chetan, Ashok, Chetan, Chetan ASHOK
ORCID: 0000-0002-5345-3658
Observed ORCID: 0000-0002-5345-3658
OpenAlex ID: A5092230715
An in-silico approach of assessments of human serotonin transporter inhibitory potential of various flavonoids for anti-depressants: molecular docking, MM-GBSA, molecular dynamics simulation studies
2023 · Sudhakar Nagarajan, Srikanth Jeyabalan, et al. · Research Square · 7
PDF
Protective role of Karanjin against bisphenol A-Induced cognitive deficits and oxidative damage in a zebrafish model
2025 · B. Logeshwari, Srikanth Jeyabalan, et al. · Scientific Reports · 4
PDF
Analytical method development for simultaneous estimation of kojic acid, ascorbic acid and niacinamide in cosmetics and its validation
2026 · Vishnu Venkatesan, Gayatri Sukumaran, et al. · BMC Chemistry · 3
Comparative neurotoxicity of Bisphenol-A and aluminum chloride in adult zebrafish: Behavioral disruption and region-specific neuropathology under chronic exposure
2025 · Logeshwari B, Srikanth Jeyabalan, et al. · Toxicology Reports · 3
Comparative evaluation of MPTP and rotenone as inducing agents for Parkinson's disease in adult zebrafish: Behavioural and histopathological insights
2025 · Chetan Ashok, Naveen Kumar Rajasekaran, et al. · Toxicology Reports · 3
Pharmacognostical and Phytochemical Screening of Leaves of Raphanus sativus Linn
2024 · Thamizharasi Suresh, Shankari Vellaisamy, et al. · Asian Journal of Pharmaceutical Research · 3
Polyherbal Formulation as a Therapeutic Strategy for Lung Cancer: Phytochemical Profiling, Molecular Docking, and Pharmacological Evaluation
2025 · Raman Lakshmi Sundaram, Thirunavukarasou Anand, et al. · Asian Pacific Journal of Cancer Prevention · 2
PDF
Exploring the Therapeutic Potential: Molecular Docking and Dynamics Studies of Lethal Factor Protease Inhibitors Targeting Bacillus Anthracis
2025 · Kamatham Sravani, Chetan Ashok, et al. · Turkish computational and theoretical chemistry/Turkish computational and theoretical chemistry : · 1
PDF
Indian medicinal plants as neuroprotective agents in Parkinson’s disease: Bridging tradition and therapeutics
2025 · Chetan Ashok, Srikanth Jeyabalan, et al. · Phytomedicine Plus · 1
Exploring flavonoids as multi-target therapeutic agents in Alzheimer's disease: Insights from Network Pharmacology, Molecular Docking, and Dynamics
2025 · Logeshwari Bala, Srikanth Jeyabalan, et al. · Journal of Applied Pharmaceutical Science · 1
PDF
In silico identification of potential inhibitors from fenugreek against the pro-inflammatory cytokine IL-17 and its receptor
2025 · Vamsi Lavu, S. Devi, et al. · Odontology · 1
Synthesis, Characterization, in Silico and in vitro Screening of Anticancer Activity of Novel Curcumin Analogues
2024 · P. Shanmugasundaram, D. Easwaramoorthy, et al. · Asian Journal of Chemistry · 1
PDF
Context-dependent effects of 6-gingerol on ferroptosis and pyroptosis in disease and therapeutics
2026 · Devaraja Dravida Pandiyan S, Srikanth Jeyabalan, et al. · Pharmacological Research - Modern Chinese Medicine
PDF
Molecular mechanisms of blood-brain barrier dysfunction caused by obesity: pathophysiological understandings and treatment targets
2026 · Roshvin Kailashnath Pillai, Vinibha Rajakumari Illankovan, et al. · Metabolic Brain Disease
Persistent lead neurotoxicity as a consequence of global regulatory failure and trade-driven exposure inequities
2026 · Naveen Kumar Rajasekaran, Chetan Ashok, et al. · Discover Public Health
PDF
Obesity-driven gut-immune-brain axis dysregulation: Emerging molecular targets and biomaterial-based interventions
2026 · Nazmul MHM, Vetriselvan Subramaniyan, et al. · Obesity Medicine
Computational discovery of emodin-based anthraquinones as PARP-1 inhibitors with relevance to ovarian and prostate cancer
2026 · Sohag Ahmed, Md Reaz Uddin, et al. · Scientific Reports
Advances in GLP-1 receptor agonists: Molecular mechanisms, drug delivery innovations, formulation strategies, and emerging therapeutic applications
2026 · Ravikanth Geddam, Sravani Kamatham, et al. · Obesity Medicine
Medicinal plants for obsessive-compulsive disorder: A review of phytotherapeutic approaches
2026 · Devaraja Dravida Pandiyan S, Srikanth Jeyabalan, et al. · Journal of Psychiatric Research
Pathophysiological impacts of lifestyle transitions on obesity: A molecular overview of metabolic dynamics
2026 · Vetriselvan Subramaniyan, Rajan Logesh, et al. · Obesity Medicine
A Novel Sustained-Release In-Situ Implant of Fluvoxamine Ameliorates Depressive-Like Behaviours in a CUMS Mouse Model
2026 · Sruthi Sruthi S, Gopinath Gopinath S, et al. · Current Trends in Biotechnology and Pharmacy
Unravelling the multi-target mechanism of methoxylated flavonoids in Parkinson's disease: Insights from network pharmacology and molecular dynamics
2026 · Chetan Ashok, Srikanth Jeyabalan, et al. · Toxicology Reports
Multi-Target therapeutic potential of 6-Gingerol in Obsessive-Compulsive Disorder: Insights from network pharmacology and molecular simulations
2026 · Devaraja Dravida Pandiyan S, Srikanth jeyabalan, et al. · SSRN Electronic Journal
Exploring the Inhibitory Potential of Podolactone B against Human Acetylcholinesterase: A Docking Study
2025 · Ashif Bahrudeen, Naveen Kumar Rajasekaran, et al. · Turkish computational and theoretical chemistry/Turkish computational and theoretical chemistry :
PDF
Molecular Docking and Molecular Dynamics of Asiaticoside and Neoandrographolide as hDHFR Inhibitors for Breast Cancer Prevention
2025 · Revathi Sugumar, Srikanth Jeyabalan, et al. · ChemistrySelect
PDF
Works count: 33
Citation count: 30
H-index: 3
I10-index:
Year
Topic
Type